Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature.

Nathalie De Brabander, Marek Wojciechowski, Koen De Decker, Annick De Weerdt, Philippe G Jorens

Journal: European journal of pediatrics 2005;164(3):158-61

PMID: 15578220

Abstract

UNLABELLED

Methanol poisoning is not frequently observed in children; however, without treatment, serious intoxication can be complicated by visual impairment, coma, metabolic acidosis, respiratory and circulatory insufficiency and death. Treatment in a paediatric intensive care is therefore compulsory. Methanol is metabolised in the liver by alcohol dehydrogenase to the toxic metabolites formaldehyde and formic acid. Classically, ethanol is given as a competitive inhibitor in order to avoid the formation of these compounds. We report on the use of fomepizole (4-methylpyrazole),a new and potent inhibitor of alcohol dehydrogenase, in a 3-year-old boy after the intake of a toxic amount of methanol. The course was uneventful and the use of fomepizole was not accompanied by any side-effects. An overview is given of all cases of paediatric poisoning in which fomepizole was used.

CONCLUSION

Fomepizole seems to be a safe and valid alternative to ethanol in cases of paediatric methanol poisoning.

Address: Department of Paediatrics, University Hospital of Antwerp, Antwerp, Belgium .
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.